Biosynthesis and turnover of 1-deoxy-sphingoid bases (Homo sapiens)
From WikiPathways
Description
Biosynthesis and turnover of 1-deoxy-sphingoid bases (1-doexySLs). 1-Deoxysphingolipids differ structurally from canonical SLs as they lack the essential C1-OH group. Consequently, 1-deoxysphingolipids cannot be converted to complex sphingolipids and are not degraded over the canonical catabolic pathways. Further conversion of 1-deoxysphingosine is done by members of the CYP4A/F family. It is however not clear which specific genes are involved in these processes.
Quality Tags
Ontology Terms
Bibliography
View all... |
- Michaels S, Wang MZ; ''The revised human liver cytochrome P450 "Pie": absolute protein quantification of CYP4F and CYP3A enzymes using targeted quantitative proteomics.''; Drug Metab Dispos, 2014 PubMed Europe PMC Scholia
- Duan J, Merrill AH Jr; ''1-Deoxysphingolipids Encountered Exogenously and Made de Novo: Dangerous Mysteries inside an Enigma.''; J Biol Chem, 2015 PubMed Europe PMC Scholia
- Karsai G, Steiner R, Kaech A, Lone MA, von Eckardstein A, Hornemann T; ''Metabolism of HSAN1- and T2DM-associated 1-deoxy-sphingolipids inhibits the migration of fibroblasts.''; J Lipid Res, 2021 PubMed Europe PMC Scholia
- Carreira AC, Santos TC, Lone MA, Zupanaciac E, Lloyd-Evans E, de Almeida RFM, Hornemann T, Silva LC; ''Mammalian sphingoid bases: Biophysical, physiological and pathological properties.''; Prog Lipid Res, 2019 PubMed Europe PMC Scholia
- Schwartz NU, Mileva I, Gurevich M, Snider J, Hannun YA, Obeid LM; ''Quantifying 1-deoxydihydroceramides and 1-deoxyceramides in mouse nervous system tissue.''; Prostaglandins Other Lipid Mediat, 2019 PubMed Europe PMC Scholia
- Simpson AE; ''The cytochrome P450 4 (CYP4) family.''; Gen Pharmacol, 1997 PubMed Europe PMC Scholia
- Lone MA, Santos T, Alecu I, Silva LC, Hornemann T; ''1-Deoxysphingolipids.''; Biochim Biophys Acta Mol Cell Biol Lipids, 2019 PubMed Europe PMC Scholia
History
View all... |
External references
DataNodes
View all... |
Name | Type | Database reference | Comment |
---|---|---|---|
1-deoxy-3-ketosphinganine | Metabolite | 67176 (ChEBI) | |
1-deoxy-dihydroceramide | Metabolite | CHEBI:67111 (ChEBI) | |
1-deoxyceramide | Metabolite | LMSP0206 (LIPID MAPS) | |
1-deoxysphingadiene | Metabolite | ||
1-deoxysphinganine-2OH | Metabolite | ||
1-deoxysphinganine-OH | Metabolite | ||
1-deoxysphinganine | Metabolite | CHEBI:67106 (ChEBI) | |
1-deoxysphingosine-OH | Metabolite | ||
1-deoxysphingosine | Metabolite | 193222-34-3 (CAS) | |
ADP | Metabolite | CHEBI:456216 (ChEBI) | |
ASAH1 | GeneProduct | ENSG00000104763 (Ensembl) | |
ATP | Metabolite | CHEBI:30616 (ChEBI) | |
CYP4A | GeneProduct | ||
CYP4F | GeneProduct | ||
CoA (16:0) | Metabolite | LMFA07050360 (LIPID MAPS) | |
CoA (18:0) | Metabolite | LMFA07050369 (LIPID MAPS) | |
CoA (20:0) | Metabolite | 15527 (ChEBI) | |
CoA (22:0) | Metabolite | LMFA07050289 (LIPID MAPS) | |
CoA (24:0) | Metabolite | LMFA07050372 (LIPID MAPS) | |
CoA (24:1) | Metabolite | LMFA07050098 (LIPID MAPS) | |
CoA (26:0) | Metabolite | LMFA07050327 (LIPID MAPS) | |
CoA (26:1) | Metabolite | ||
H2O | Metabolite | CHEBI:15377 (ChEBI) | |
KDSR | GeneProduct | ENSG00000119537 (Ensembl) | |
L-alanine | Metabolite | CHEBI:16977 (ChEBI) | |
Palmitoyl-CoA | Metabolite | CHEBI:15525 (ChEBI) | |
SGPP1 | GeneProduct | ENSG00000126821 (Ensembl) | |
SGPP2 | GeneProduct | ENSG00000163082 (Ensembl) | |
SPHK1 | GeneProduct | ENSG00000176170 (Ensembl) | |
SPHK2 | GeneProduct | ENSG00000063176 (Ensembl) | |
SPTLC1 | GeneProduct | ENSG00000090054 (Ensembl) | |
SPTLC2 | GeneProduct | ENSG00000100596 (Ensembl) | |
desaturases | Protein | ||
sphingolipid metabolism pathway | Pathway | WP4344 (WikiPathways) |
Annotated Interactions
No annotated interactions